![A survey of optimal strategy for signature-based drug repositioning and an application to liver cancer | eLife A survey of optimal strategy for signature-based drug repositioning and an application to liver cancer | eLife](https://iiif.elifesciences.org/lax/71880%2Felife-71880-fig7-v2.tif/full/1500,/0/default.jpg)
A survey of optimal strategy for signature-based drug repositioning and an application to liver cancer | eLife
![NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen‐pulsed dendritic cells - Shibolet - 2003 - International Journal of Cancer - Wiley Online Library NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen‐pulsed dendritic cells - Shibolet - 2003 - International Journal of Cancer - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/7e2e5cee-688a-48ad-a352-98bff64959cb/mfig001.gif)
NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen‐pulsed dendritic cells - Shibolet - 2003 - International Journal of Cancer - Wiley Online Library
![Characterization of the NiRAN domain from RNA-dependent RNA polymerase provides insights into a potential therapeutic target against SARS-CoV-2 | bioRxiv Characterization of the NiRAN domain from RNA-dependent RNA polymerase provides insights into a potential therapeutic target against SARS-CoV-2 | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2021/02/03/2021.02.03.429510/F1.large.jpg)
Characterization of the NiRAN domain from RNA-dependent RNA polymerase provides insights into a potential therapeutic target against SARS-CoV-2 | bioRxiv
![Prevalence and role of low skeletal muscle mass (LSMM) in hepatocellular carcinoma. A systematic review and meta-analysis - Clinical Nutrition ESPEN Prevalence and role of low skeletal muscle mass (LSMM) in hepatocellular carcinoma. A systematic review and meta-analysis - Clinical Nutrition ESPEN](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/29302fa7-2775-4b63-9160-705a94515da1/gr1.jpg)
Prevalence and role of low skeletal muscle mass (LSMM) in hepatocellular carcinoma. A systematic review and meta-analysis - Clinical Nutrition ESPEN
![Maillots de bain mode femme - grand choix de Maillots & Shorts de bain - Livraison Gratuite | Spartoo ! Maillots de bain mode femme - grand choix de Maillots & Shorts de bain - Livraison Gratuite | Spartoo !](https://photos6.spartoo.com/photos/213/21323922/21323922_350_A.jpg)
Maillots de bain mode femme - grand choix de Maillots & Shorts de bain - Livraison Gratuite | Spartoo !
![Diseases | Free Full-Text | A Surgical Perspective on Targeted Therapy of Hepatocellular Carcinoma | HTML Diseases | Free Full-Text | A Surgical Perspective on Targeted Therapy of Hepatocellular Carcinoma | HTML](https://www.mdpi.com/diseases/diseases-03-00221/article_deploy/html/images/diseases-03-00221-ag-550.jpg)
Diseases | Free Full-Text | A Surgical Perspective on Targeted Therapy of Hepatocellular Carcinoma | HTML
![Characterization of the NiRAN domain from RNA-dependent RNA polymerase provides insights into a potential therapeutic target against SARS-CoV-2 | bioRxiv Characterization of the NiRAN domain from RNA-dependent RNA polymerase provides insights into a potential therapeutic target against SARS-CoV-2 | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2021/02/03/2021.02.03.429510/F4.large.jpg)
Characterization of the NiRAN domain from RNA-dependent RNA polymerase provides insights into a potential therapeutic target against SARS-CoV-2 | bioRxiv
![What to do about Hepatocellular Carcinoma: Recommendations for Health Authorities: An International Liver Cancer Association Advocacy Document - JHEP Reports What to do about Hepatocellular Carcinoma: Recommendations for Health Authorities: An International Liver Cancer Association Advocacy Document - JHEP Reports](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/d7370ee5-1cee-403b-9ba0-ebd3120d7d38/gr1_lrg.jpg)
What to do about Hepatocellular Carcinoma: Recommendations for Health Authorities: An International Liver Cancer Association Advocacy Document - JHEP Reports
![ALBI grade: Evidence for an improved model for liver functional estimation in patients with hepatocellular carcinoma - JHEP Reports ALBI grade: Evidence for an improved model for liver functional estimation in patients with hepatocellular carcinoma - JHEP Reports](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/b528dceb-8188-42e7-9690-b08ebd4cd443/gr1_lrg.jpg)
ALBI grade: Evidence for an improved model for liver functional estimation in patients with hepatocellular carcinoma - JHEP Reports
![Integrative Quantitative Proteomics Unveils Proteostasis Imbalance in Human Hepatocellular Carcinoma Developed on Nonfibrotic Livers* - Molecular & Cellular Proteomics Integrative Quantitative Proteomics Unveils Proteostasis Imbalance in Human Hepatocellular Carcinoma Developed on Nonfibrotic Livers* - Molecular & Cellular Proteomics](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/fe132466-e2dc-470c-8216-a19b225f446f/gr1_lrg.jpg)
Integrative Quantitative Proteomics Unveils Proteostasis Imbalance in Human Hepatocellular Carcinoma Developed on Nonfibrotic Livers* - Molecular & Cellular Proteomics
![A survey of optimal strategy for signature-based drug repositioning and an application to liver cancer | bioRxiv A survey of optimal strategy for signature-based drug repositioning and an application to liver cancer | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2021/06/30/2021.06.29.450305/F3.large.jpg)
A survey of optimal strategy for signature-based drug repositioning and an application to liver cancer | bioRxiv
![A survey of optimal strategy for signature-based drug repositioning and an application to liver cancer | eLife A survey of optimal strategy for signature-based drug repositioning and an application to liver cancer | eLife](https://iiif.elifesciences.org/lax/71880%2Felife-71880-fig6-v2.tif/full/,1500/0/default.jpg)